Skip to main content
. 2020 Apr 27;103(3):1319–1328. doi: 10.4269/ajtmh.19-0613

Table 4.

Cause-specific mortality by intention-to-treat for the four main inferred causes of death in the study area using InterVA

Deaths/person-years Rate per 1,000 person-years (95% CI) Rate ratio* (95% CI) P-value
Pneumonia
 Placebo 94/66,935 1.40 (1.15–1.72) 1
 Azithromycin 77/66,837 1.15 (0.92–1.44) 0.82 (0.60–1.12) 0.22
Malaria
 Placebo 256/66,935 3.82 (3.38–4.32) 1
 Azithromycin 245/66,837 3.67 (3.23–4.15) 0.95 (0.78–1.16) 0.64
HIV/AIDS
 Placebo 103/66,935 1.54 (1.27–1.87) 1
 Azithromycin 71/66,837 1.06 (0.84–1.34) 0.70 (0.50–0.97) 0.03
Diarrhea
 Placebo 48/66,935 0.72 (0.54–0.95) 1
 Azithromycin 45/66,837 0.67 (0.50–0.90) 0.95 (0.61–1.49) 0.84
*

From random-effects Poisson model adjusting for clustering at the level of the randomization unit.